×
We have detected your country as:
Please click here to go to the USA website or select another country from the dropdown list.
We have detected your country as:
Please click here to go to the USA website or select another country from the dropdown list.
Animal model experiments revealed that some 90% of animals treated with the gel survived a heart attack, while among those untreated only 40% survived. The latest trial is a clinical trial consisting of 23 patients in Germany and Belgium. “They are doing fine,” says company representative Dganit Bar. Toxicity tests have shown the product is safe.
Based on a common brown seaweed with other active ingredients, Bar believes that the product could see very swift development, as early as 2012. The quick time to market has to do with the fact that it is being marketed as a medical device and not a drug, says Bar. For more information: info@BioLineRx.com, 972-2-548-9100.
Excerpts from an article by Karin Kloosterman, www.israel21c.org
Photo Credit:
All logos and trademarks in this site are property of their respective owner. All other materials are property of Bridges for Peace. Copyright © 2024.
Website Site Design by J-Town Internet Services Ltd. - Based in Jerusalem and Serving the World.
